French Software Stock News

Renault (ENXTPA:RNO) is back in focus after the High Court of Justice in England & Wales rejected all diesel emissions claims against the company, while management shifts and R&D expansion in China reshape its risk and technology profile. See our latest analysis for Renault. Despite the High Court ruling and fresh leadership appointments, Renault’s 1-year total shareholder return is down 32.0%, with the share price falling 29.0% year to date and 16.8% over 90 days. This suggests recent...

Eramet (ENXTPA:ERA) is back in focus after signing a Letter of Intent with Harfang Exploration for a potential joint venture on the Serpent lithium focused project in Québec, marking a fresh North American critical minerals push. See our latest analysis for ERAMET. The LOI comes after a weaker run for ERAMET's share price, with the 30 day share price return down 20.04% and the year to date share price return down 28.41%. The 1 year total shareholder return is down 12.67%, pointing to fading...

JCDecaux (ENXTPA:DEC) has renewed its advertising contract with Heathrow, securing an 8 year agreement from January 2027 that will keep the company in charge of more than 680 digital screens and premium airport assets. See our latest analysis for JCDecaux. JCDecaux’s recent Heathrow renewal and the February 2026 launch of its global programmatic DOOH offer come as the stock shows firm momentum, with a 30 day share price return of 14.90% and a 1 year total shareholder return of 41.77%. If you...

BNP Paribas (ENXTPA:BNP) is in focus after joining Swift’s blockchain based pilot for 24/7 tokenized deposit payments and appointing former Jain Global portfolio manager Kavi Gupta to lead FICC trading in the Americas. See our latest analysis for BNP Paribas. The recent Swift pilot news and leadership change come as BNP Paribas trades around €100.70, with a 30 day share price return of 4.15% and year to date share price return of 22.92%. Its 1 year total shareholder return of 39.98% and 5...

TFF Group ( EPA:TFF ) shareholders are probably feeling a little disappointed, since its shares fell 2.3% to €15.44 in...

Sanofi’s share price has inched higher by 7.5% over the past five years, a modest return that sits alongside a high value score and a recent stream of product and R&D updates. This raises the question of whether the stock quietly leans cheap or is fairly priced for its current prospects. A 7.5% return over five years suggests Sanofi has delivered only a small gain for long term holders, so any valuation upside today may matter more for investors looking ahead. Regulatory progress around...

Renault’s share price has fallen sharply over the past year, yet its current market price sits well below an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach, with market multiples pointing in the same undervalued direction. Renault stock is down 32.6% over the past year, which has increased investor focus on whether the current price already reflects the bad news. The recent High Court ruling in England & Wales in favor of Renault on diesel emissions litigation may...

With inflation trends, energy prices and central bank decisions all tugging at markets, many investors are looking for income that feels more predictable than share price swings. The Dividend Powerhouses (3%+ Yield) screener focuses on companies offering higher dividend yields that are paid from earnings, with payments that have been stable or growing. That can appeal if you want cash flows that do not solely depend on short term market sentiment. In this article, three of the strongest...

Luxury consumption in the US is increasingly shaped by a K shaped economy, where affluent households, supported by strong wage growth, rising equity markets and high home values, keep spending even as many middle income consumers feel the strain of tighter credit. With the S&P 500 up 73.4% over five years and core PCE inflation at 3.4%, this wealth driven demand is reshaping which consumer stocks may benefit. This article walks through 3 stocks from the US Luxury Consumption Leaders screener...

Tariff headlines are back in focus, but this time commercial aircraft, engines, and components sit on the sidelines of new US measures, which keeps global supply chains open for key aerospace stocks. That policy twist has implications for companies like Boeing and Airbus, as well as the suppliers that keep their production lines moving. For investors watching trade policy risk and supply chain resilience, this screener highlights stocks most exposed to the latest news. Below, you will find 3...

L'Air Liquide (ENXTPA:AI) has outlined two large U.S. projects, including a planned Partial Oxidation unit in Texas and new ultra pure gas facilities in Indiana, drawing renewed attention to the stock. See our latest analysis for L'Air Liquide. L'Air Liquide's recent U.S. investments come as the stock trades around €174.3, with a year to date share price return of 20.58% but a softer 7 day share price move, while the 5 year total shareholder return of 70.86% reflects steadier long term...

The second-quarter results for Kaufman & Broad S.A. ( EPA:KOF ) were released last week, making it a good time to...

Linedata Services S.A. ( EPA:LIN ) stock is about to trade ex-dividend in three days. Typically, the ex-dividend date...

Hermès announced that Nadège Vanhée will present the house’s first haute couture runway show with a made-to-measure collection at Paris Couture Week, while Grace Wales Bonner will make her debut as creative director of menswear, both scheduled for January 2027. This move signals Hermès’ deeper push into ultra-high-end, bespoke fashion and a refreshed creative direction across both women’s and men’s collections. We’ll now explore how Hermès’ first haute couture runway show and bespoke...

Société Anonyme des Bains de Mer et du Cercle des Étrangers à Monaco (ENXTPA:BAIN) has opened FY 2026 with first half revenue of €542.5 million and basic EPS of €5.18, setting the tone against a current share price of €139. The company has seen revenue move from €495.1 million and EPS of €4.88 in 1H 2025 to €272.9 million with EPS of €0.39 loss in 2H 2025, before reaching the latest 1H 2026 levels, with trailing EPS growth of 2.5% over the last year and a net margin of 13.1% that sits below...

Technip Energies (ENXTPA:TE) stock is in focus after the company, together with Alterra and Neste, announced Nerea™, a standardized and modular industrial offering aimed at scaling chemical recycling of hard-to-recycle plastic waste. See our latest analysis for Technip Energies. At a share price of €34.1, Technip Energies has a 1-day share price return of 0.71% and a 7-day share price return of 2.16%. Its 90-day share price return is down 12.83%, while the 3-year total shareholder return of...

Carmila (ENXTPA:CARM) has agreed to acquire the Grand Quetigny shopping centre in Dijon for €45 million. The deal is expected to be accretive to earnings and aligned with its value focused investment policy. See our latest analysis for Carmila. The acquisition comes after a mixed period for Carmila’s stock, with the share price at €16.66. The recent 30-day share price return is positive, but the 90-day share price return is lower. Meanwhile, a 1-year total shareholder return of 7.9% and a...

The European market has recently shown positive momentum, with the STOXX Europe 600 Index rising by 1.96% and inflation rates in the eurozone coming in lower than expected, easing concerns about potential interest rate hikes. In this dynamic environment, high growth tech stocks in Europe are gaining attention for their potential to capitalize on favorable economic conditions and investor sentiment, making them an intriguing area of focus for those looking to explore opportunities within the...

Valeo (ENXTPA:FR) has drawn fresh investor attention after appointing Jean-Luc Terrasse as chief executive officer of its Light Division and group executive vice president, a leadership change that places this core segment under new oversight. See our latest analysis for Valeo. At a share price of €12.46, Valeo has seen a 1-day share price return of 2.30%, while the 30-day share price return is down 14.22%. The 1-year total shareholder return of 26.94% contrasts with weaker three and five...

Hermès International Société en commandite par actions (ENXTPA:RMS) is drawing fresh attention after announcing its first haute couture runway show at Paris Couture Week, along with new menswear leadership set to debut next January. See our latest analysis for Hermès International Société en commandite par actions. The couture and menswear announcements arrive at a time when Hermès International Société en commandite par actions has seen its share price fall 22.79% year to date, with a 1 year...

As of early July 2026, European markets have shown resilience with the STOXX Europe 600 Index rising by nearly 2%, buoyed by lower oil prices and easing inflation concerns. In this environment, dividend stocks can offer a stable income stream, providing potential benefits for investors seeking to navigate the current economic landscape while capitalizing on consistent returns.

Thales (ENXTPA:HO) is back in focus after Germany terminated the F126 frigates contract, prompting the group to flag an exceptional mostly non cash charge and to confirm plans to seek compensation. See our latest analysis for Thales. Despite the F126 setback and the planned acquisition of the Gorgé family’s stake in Exail, Thales’ 1 day share price return declined 1.64% to €233.7, while its 1 year total shareholder return is down 4.03%. However, it remains very strong at 80.38% over three...

While Compagnie Chargeurs Invest ( EPA:CRI ) might not have the largest market cap around , it saw a significant share...

In recent days, Adocia reported that Sanofi’s three-year exclusive negotiation right on the obesity-focused M1Pram combo therapy expired, while separately Sanofi announced positive Phase 3 Baby-COMET results for Nexviazyme in infants with infantile-onset Pompe disease and plans a US label-extension filing in the second half of 2026. Together with an ongoing EU antitrust probe into alleged disparaging flu-vaccine communications, these developments highlight both Sanofi’s rare-disease R&D...